Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis
Frank Bridoux(Université de Poitiers), P. Vanhille(Centre Hospitalier de Valenciennes), D. Fleury(Centre Hospitalier de Valenciennes), V. Lemaı̂tre(UCLouvain), J.-L. Pallot(Centre hospitalier Robert-Ballanger), D Kleinknecht(Hôpital Necker-Enfants Malades), Marc Hazzan
Cited by 65
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520